CLOSURE MEDICAL's DERMABOND LIQUID TISSUE ADHESIVE LABELING SHOULD INCLUDE REMINDER ON WOUND CLEANSING, CONTRAINDICATION FOR MULTIPLE TRAUMA -- FDA PANEL
This article was originally published in The Gray Sheet
Executive Summary
Labeling for Closure Medical's DermaBond liquid tissue adhesive product should include a reminder that clinicians adequately cleanse wounds prior to application to address an increased rate of suspected infections observed in clinical trials versus controls, FDA's General and Plastic Surgery Devices Panel recommended Jan. 30.